Quantcast

Latest Lawrence Corey Stories

Herpes Vaccine Could Arise Due To Suppressive Immune Cell Discovery
2013-05-09 07:57:40

Lawrence LeBlond for redOrbit.com - Your Universe Online Herpes is an infectious disease that affects more than 24 million people in the United States alone, according to a recent report by the US Centers for Disease Control and Prevention (CDC). Now, researchers have identified a class of immune cells that exist in genital skin and mucosa that may play a role in developing a vaccine to prevent one of the most common sexually transmitted infections (STIs) in America. These immune cells,...

2010-07-30 12:04:00

SEATTLE, July 30 /PRNewswire/ -- The Fred Hutchinson Cancer Research Center board of trustees today announced the selection of Lawrence Corey, M.D., an internationally renowned expert in virology, immunology and vaccine development, as its new president and director. He is expected to begin responsibilities as the Center's new leader on Jan. 1, 2011. The board selected Corey for his leadership and expertise on a number of fronts, including scientific accomplishments and vision, management...

2010-01-25 15:04:01

Research from a five-year international clinical study shows that acyclovir, a commonly prescribed drug used to suppress symptoms of the herpes virus, does not affect HIV transmission by people with both viruses. The study, conducted by the Partners in Prevention HSV/HIV Transmission Study, was released by the New England Journal of Medicine in its online edition Jan. 20 and will follow in the print edition Feb. 4. The largest risk group worldwide, but particularly in Africa and Asia, for...

2009-08-02 12:55:00

New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Scientists have uncovered details of an immune-cell environment conducive to HIV infection that persists at the location of HSV-2 genital skin lesions long after they have been treated with oral doses of the drug acyclovir and have healed and the skin...

2009-05-13 00:46:37

Acyclovir, a drug that suppresses herpes simplex virus-2, does not reduce HIV risk when taken by people infected by HIV and herpes, U.S. researchers said. The majority of people with HIV infection also have herpes simplex virus-2 infection. Multiple studies have shown that frequent genital herpes recurrences increase the amount of HIV in the blood and genital tract. The HIV virus is also shed from genital herpes ulcers and individuals with such ulcers transmit HIV to others more efficiently,...

2008-12-16 17:04:00

SEATTLE, Dec. 16 /PRNewswire/ -- The Washington Life Sciences Discovery Fund (LSDF) has awarded nearly $4.7 million to launch the start-up phase of the Washington Vaccine Alliance (WAVA) and to support initial research into three new vaccines for E. coli, herpes and syphilis. Announced today, the grant is funded by Washington's$350 million tobacco-lawsuit-settlement bonus and provides essential funding to bring this innovative new organization to life. WAVA core operations during the...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.